Robert Qi Luo is a highly motivated and collaborative pharmaceutical research scientist with over eight years of drug discovery experience in the pharmaceutical industry and seven years of academic research in inflammation, immunology, and respiratory diseases. They have successfully designed and developed various in vitro, cellular, and ex vivo models to identify and validate drug targets for multiple therapeutic programs, including fibrosis. Their impressive record includes authorship of three first-author and eight co-author publications in peer-reviewed journals. Currently, they serve as a Senior Principal Biologist at Eli Lilly and Company, continuing to advance research in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices